Advertisement

Topics

Canada InVitro Diagnostics Market Segmented by Technique, by Product, by Applications, by End User Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3000

16:46 EDT 21 Jul 2018 | BioPortfolio Reports

The Canada in vitro diagnostics market in emerging economies was estimated at USD 3,391.10 million in 2017. The market is expected to reach USD 5,890.54 million by 2023, at a CAGR of 9.64% during the forecast period, 20182023. Currently, North America dominates the global market, with the market yet to reach saturation. The Canada is the leading market both globally and in North America.


Rapid Adoption of Advanced Diagnostics


The rapid adoption of the numerous number of innovative IVD methods such as digital PCR, mass spectrophotometry, chromosome analysis, tissue microarrays, next gen sequencing and cell signaling pathway testing are currently driving the growth of the market. In the nextgeneration sequencing based IVDs, several sequencingbased diagnostic tests and test services have been recently launched, including Althea Diagnostics' BRAF mutations test, Sequenta's LymphoSIGHT, and Enzo's MultiGEN multiplex DNA sequencing.

The increasing incidences of the chronic and infectious diseases, rise in the geriatric population are also the some of the factors which drives the IVD market in Canada region. Furthermore, the increase in the investments for the advancement of healthcare sector by the government is also anticipated to boost the growth of the market.


Opportunities arising from increasing investment in the sector


The common trend that is being observed here is that the leading players are acquiring the smaller technological companies to produce the companion diagnostic tests; while the pharmaceutical companies, attracted by the opportunities in the IVD market, both are investing and collaborating with diagnostic devices companies to extend their drugs market after major patent expirations. Roche Diagnostics and Abbott Laboratories are an example of the major companies in the market, which focus on achieving the synergy between their diagnostic solutions and pharmaceutical solutions.

Some of the factors are the lack of proper reimbursements policies and stringent regulatory framework which are also limiting the growth of the market.


Canada becomes the leading market


Canada is the gradually becoming the market leader for both globally and North America. Canada is the next biggest market in the North America region for the invitro diagnostics. This is due to the advances on the technology forefront and the higher GDP of the nation. This growth is developing the need to analyze, review and forecast the growth of the InVitro Diagnostics market.


Key Developments in the Market


September, 2016: Thermo Fisher Scientific completes the acquisition of FEI Company

August, 2016: Thermo Fisher Scientific partners with Hamilton Bonaduz AG to accelerate automation platforms access for forensic customers.

September, 2016: Roche announced the launch of its DISCOVERY 5Plex procedure and reagents for immunohistochemistry IHC research applications. It is the first preoptimized, fully automated multiplex procedure available on the VENTANA DISCOVERY ULTRA2 instrument.


Key players: ABBOTT DIAGNOSTICS, BAYER DIABETES CARE/PANASONIC HEALTHCARE, BECTON DICKINSON AND COMPANY, BIOMERIEUX, BIORAD LABORATORIES Inc., DANAHER CORPORATION, HOLOGIC and ROCHE DIAGNOSTICS.


Reasons to Purchase this Report


Current and future Canada in vitro diagnostics market outlook in the developed and emerging markets

Analyzing various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players.

3 months analyst support along with the Market Estimate sheet in excel.


Customization of the Report


This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Original Article: Canada InVitro Diagnostics Market Segmented by Technique, by Product, by Applications, by End User Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3000

NEXT ARTICLE

More From BioPortfolio on "Canada InVitro Diagnostics Market Segmented by Technique, by Product, by Applications, by End User Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3000"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...